Literature DB >> 23379491

Level of C-reactive protein in chronic hemodialysis patients: a comparative study between patients with non-infected catheters and arteriovenous fistula in a large Saudi hemodialysis center.

Khalid Al Saran1, Alaa Sabry, Medhat Shalaby, Sherrine Al Sherbeiny, Mohamed Abdelkader.   

Abstract

Central venous catheters are associated with infection and resultant higher C-reactive protein levels (CRP), suggesting that catheters may be an important determinant of increased inflammatory response. The increased levels of markers such as CRP are associated with increased risk of premature death and hospitalization in end stage renal disease (ESRD) patients on regular hemodialysis (HD). In this prospective study the mean levels of the inflammatory marker CRP were measured every 2 months over a period of 6 months by using immunoturbidimetric assay in 70 ESRD patients on maintenance HD at Prince Salman Center For Kidney Diseases (PSCKD) who met our inclusion criteria, comparing those dialyzed using a non-infected catheter (35 patients) to those using arteriovenous fistulas (35 patients). Seventy ESRD patients who had been on maintenance HD for more than 6 months were included in the study, with a mean age of 50.09 ± 15.61 years, 80% were males and 20% were females. Serial levels of mean CRP were statistically significantly higher in the group with non-infected catheters (0.83, 0.82, 0.94 mg/dL) compared with those with arteriovenous fistula (0.31, 0.38 and 0.34 mg/dL) with P-values of 0.000, 0.023 and 0.001, respectively. In our study we found no relationship between CRP level and age, sex, hemoglobin albumin, calcium, phosphorus and intact parathyroid hormone level in both groups. Our study shows that catheters might contribute to increased inflammation independent of infection, and support the avoidance of catheters and a timely conversion to fistulas with catheter removal.
© 2012 The Authors. Therapeutic Apheresis and Dialysis © 2012 International Society for Apheresis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23379491     DOI: 10.1111/j.1744-9987.2012.01116.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  5 in total

1.  A linear relationship between serum high-sensitive C-reactive protein and hemoglobin in hemodialysis patients.

Authors:  Behzad Heidari; Muhammad Reza Fazli; Muhammad Ali Ghazi Misaeid; Parham Heidari; Niloofar Hakimi; Abbas Ali Zeraati
Journal:  Clin Exp Nephrol       Date:  2014-11-08       Impact factor: 2.801

2.  Tunneled catheters with taurolidine-citrate-heparin lock solution significantly improve the inflammatory profile of hemodialysis patients.

Authors:  Néstor Fontseré; Celia Cardozo; Javier Donate; Alex Soriano; Mercedes Muros; Mercedes Pons; Josep Mensa; Josep M Campistol; Juan F Navarro-González; Francisco Maduell
Journal:  Antimicrob Agents Chemother       Date:  2014-05-12       Impact factor: 5.191

3.  Intradialytic training in patients with end-stage renal disease: a systematic review and meta-analysis of randomized clinical trials assessing the effects of five different training interventions.

Authors:  Filipe Ferrari; Lucas Helal; Thiago Dipp; Douglas Soares; Ângela Soldatelli; Andrew Lee Mills; Cláudio Paz; Mário César Carvalho Tenório; Marcelo Trotte Motta; Franklin Correa Barcellos; Ricardo Stein
Journal:  J Nephrol       Date:  2019-12-21       Impact factor: 3.902

4.  Effect of Vitamin C Supplementation on C-reactive Protein Levels in Patients Undergoing Hemodialysis: A Randomized, Double Blind, Placebo-Controlled Study.

Authors:  Vajihe Biniaz; Mehdi Sadeghi Shermeh; Abbas Ebadi; Ali Tayebi; Behzad Einollahi
Journal:  Nephrourol Mon       Date:  2013-11-27

5.  Quantification of Lipoteichoic Acid in Hemodialysis Patients With Central Venous Catheters.

Authors:  Amy Barton Pai; Adinoyi Garba; Paul Neumann; Alexander J Prokopienko; Gabrielle Costello; Michael C Dean; Sriram Narsipur
Journal:  Front Med (Lausanne)       Date:  2018-11-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.